Patents by Inventor Amy Jean Brisben

Amy Jean Brisben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230103473
    Abstract: Systems and methods for monitoring physiologic response to Valsalva maneuver (VM) are disclosed. An exemplary patient monitor may detect a natural incidence of a VM session occurred in an ambulatory setting using a heart sound (HS) signal sensed from the patient. The patient monitor may include a physiologic response analyzer to sense patient physiologic response during the detected VM session, and generate a cardiovascular or autonomic function indicator based on the sensed physiologic response to the VM. Using the physiologic response to the VM, the system may detect a target physiologic event using the sensed physiologic response to the VM.
    Type: Application
    Filed: December 5, 2022
    Publication date: April 6, 2023
    Inventors: Pramodsingh Hirasingh Thakur, David J. Ternes, Ashley Moriah Jensen, Qi An, Amy Jean Brisben
  • Patent number: 11523743
    Abstract: Systems and methods for monitoring physiologic response to Valsalva maneuver (VM) are disclosed. An exemplary patient monitor may detect a natural incidence of a VM session occurred in an ambulatory setting using a heart sound (HS) signal sensed from the patient. The patient monitor may include a physiologic response analyzer to sense patient physiologic response during the detected VM session, and generate a cardiovascular or autonomic function indicator based on the sensed physiologic response to the VM. Using the physiologic response to the VM, the system may detect a target physiologic event using the sensed physiologic response to the VM.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: December 13, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Pramodsingh Hirasingh Thakur, David J. Ternes, Ashley Moriah Jensen, Qi An, Amy Jean Brisben
  • Patent number: 11497921
    Abstract: Systems, methods and implantable devices configured to provide cardiac resynchronization therapy and/or bradycardia pacing therapy. A first device located in the heart of the patient is configured to receive a communication from a second device and deliver a pacing therapy in response to or in accordance with the received communication. A second device located elsewhere is configured to determine an atrial event has occurred and communicate to the first device to trigger the pacing therapy. The second device may be configured for sensing the atrial event by the use of vector selection and atrial event windowing, among other enhancements. Exception cases are discussed and handled as well.
    Type: Grant
    Filed: November 12, 2019
    Date of Patent: November 15, 2022
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Stephen J. Hahn, Krzysztof Z. Siejko, William J. Linder, Keith R. Maile, Amy Jean Brisben, Keith L. Herrmann, Brendan E. Koop, Benjamin J. Haasl
  • Patent number: 11464982
    Abstract: Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) and an extracardiac device (ED). The LCP is configured to deliver pacing therapy at a pacing interval. Illustratively, the ED may be configured to analyze the cardiac cycle including a portion preceding the pacing therapy delivery for one or several cardiac cycles, and determine whether an interval from the P-wave to the pace therapy in the cardiac cycle(s) is in a desired range. In an example, if the P-wave to pace interval is outside the desired range, the ED communicates to the LCP to adjust the pacing interval.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: October 11, 2022
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Stephen J. Hahn, Krzysztof Z. Siejko, Amy Jean Brisben, Keith R. Maile
  • Patent number: 11278232
    Abstract: New and alternative approaches to the monitoring of cardiac signal quality for external and/or implantable cardiac devices. In one example, signal quality is monitored continuously or in response to a triggering event or condition and, upon identification of a reduction in signal quality, a device may reconfigure its sensing state. In another example, one or more trends of signal quality are monitored by a device, either continuously or in response to a triggering event or condition, and sensing reconfiguration may be performed in response to identified trends and events. In yet another example, a device may use a looping data capture mode to track sensing data in multiple vectors while primarily relying on less than all sensing vectors to make decisions and, in response to a triggering event or condition, the looped data can be analyzed automatically, without waiting for additional data capture to reconfigure sensing upon identification of the triggering event or condition.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: March 22, 2022
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Amy Jean Brisben, Venugopal Allavatam, Krzysztof Z. Siejko, Deepa Mahajan, Kevin G. Wika, Keith L. Herrmann, Stephen J. Hahn
  • Patent number: 11202601
    Abstract: This document discusses, among other things, systems and methods for monitoring a patient at risk of epilepsy. A system comprises a sensor circuit that senses from the patient at least first and second physiological or functional signals. A wellness detector circuit can detect an epileptic event using the sensed physiological or functional signals, or additionally classify the epileptic event into one of epileptic seizure types. The system can generate a wellness indicator based on a trend of the physiological or functional signal during the detected epileptic event. The wellness indicator indicates an impact of the detected epileptic event on the health status of the patient. The system includes an output unit configured to output the detection of the epileptic event or the wellness indicator to a user or a process.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: December 21, 2021
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: David J. Ternes, Pramodsingh Hirasingh Thakur, Qi An, Amy Jean Brisben, Stephen B. Ruble, Keith R. Maile
  • Patent number: 11089958
    Abstract: Systems and methods for managing machine-generated medical events detected from one or more patients are described herein. A medical event management system includes an event analyzer circuit to detect a medical event using physiological data from a patient-triggered episode acquired from a medical device. The event analyzer circuit determines a confidence score of the medical event detection, and generates an alignment indicator indicating a degree of concordance between the detected medical event and the information about the patient-triggered episode. The system assigns priority information to the patient-triggered episode using the generated alignment indicator and the confidence score of the detection. An output circuit can output the received physiological information to a user or a process according to the assigned priority information.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: August 17, 2021
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Amy Jean Brisben, Qi An, Pramodsingh Hirasingh Thakur, David J. Ternes, JoAnna Trapp Simpson, Viktoria A. Averina, Deepa Mahajan, Sunipa Saha, Krzysztof Z. Siejko
  • Patent number: 11052255
    Abstract: Systems and methods for pacing cardiac conductive tissue are described. A medical system includes an electrostimulation circuit to generate His-bundle pacing (HBP) pulses. A sensing circuit senses a physiologic signal, and detect a local His-bundle activation discrete from a pacing artifact of the HBP pulse. A control circuit verifies capture status in response to the HBP pulses. Based on the capture status, the control circuit determines one or more pacing thresholds including a selective HBP threshold representing a threshold strength to capture only the His bundle but not the local myocardium, and a non-selective HBP threshold representing a threshold strength to capture both the His bundle and the local myocardium. The electrostimulation circuit may deliver HBP pulses based on the selective and non-selective HBP thresholds.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: July 6, 2021
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Amy Jean Brisben, David J. Ternes, Allan Charles Shuros, Deepa Mahajan, David L. Perschbacher
  • Publication number: 20210145289
    Abstract: An apparatus includes a posture sensing circuit configured to detect a change in posture of a subject; a cardiac signal sensing circuit configured to generate a sensed cardiac signal, wherein the sensed cardiac signal includes heart rate information of the subject; a physiologic sensing circuit configured to generate a sensed physiologic signal, wherein the physiologic signal includes information related to blood pressure of the subject; a storage buffer; and a control circuit operatively coupled to the posture sensing circuit and the storage buffer. The control circuit is configured to initiate storage of the heart rate information and the information related to blood pressure in response to a detected change in posture of the subject.
    Type: Application
    Filed: November 16, 2020
    Publication date: May 20, 2021
    Inventors: Pramodsingh Hirasingh Thakur, David J. Ternes, Amy Jean Brisben, Qi An
  • Patent number: 10849568
    Abstract: Systems and methods for monitoring patient for syncope are discussed. A syncope monitor system can detect a precipitating event associated with a syncope onset, and acquire hemodynamic data in response to the detection of the precipitating event. A syncope analyzer circuit may generate temporal profiles of one or more hemodynamic parameters using the hemodynamic data. The syncope analyzer may use the temporal profiles to detect a syncopal event and to classify the syncopal event into one of a plurality of syncope categories. The detection and classification information may be output to a user or a process.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: December 1, 2020
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Qi An, Pramodsingh Hirasingh Thakur, Amy Jean Brisben, Jeffrey E. Stahmann, David J. Ternes
  • Patent number: 10849524
    Abstract: Methods and devices adapted for cardiac signal analysis. A method or device has accessible to it more than one approach to cardiac cycle rate analysis and is adapted to monitor sensing signal quality. In response to an apparent reduction in signal quality or other trigger, the method or device checks whether an arrhythmia or an actual drop in signal quality is occurring prior to modifying sensing configurations or parameters.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: December 1, 2020
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Amy Jean Brisben, Krzysztof Z. Siejko, Thomas V. Karathanos
  • Publication number: 20200360699
    Abstract: Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) and an extracardiac device (ED). The LCP is configured to deliver pacing therapy at a pacing interval. Illustratively, the ED may be configured to analyze the cardiac cycle including a portion preceding the pacing therapy delivery for one or several cardiac cycles, and determine whether an interval from the P-wave to the pace therapy in the cardiac cycle(s) is in a desired range. In an example, if the P-wave to pace interval is outside the desired range, the ED communicates to the LCP to adjust the pacing interval.
    Type: Application
    Filed: August 5, 2020
    Publication date: November 19, 2020
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: STEPHEN J. HAHN, KRZYSZTOF Z. SIEJKO, AMY JEAN BRISBEN, KEITH R. MAILE
  • Patent number: 10780278
    Abstract: Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) and an extracardiac device (ED). The LCP is configured to deliver pacing therapy at a pacing interval. Illustratively, the ED may be configured to analyze the cardiac cycle including a portion preceding the pacing therapy delivery for one or several cardiac cycles, and determine whether an interval from the P-wave to the pace therapy in the cardiac cycle(s) is in a desired range. In an example, if the P-wave to pace interval is outside the desired range, the ED communicates to the LCP to adjust the pacing interval.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: September 22, 2020
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Stephen J. Hahn, Krzysztof Z. Siejko, Amy Jean Brisben, Keith R. Maile, Jr.
  • Publication number: 20200094063
    Abstract: Systems, methods and implantable devices configured to provide cardiac resynchronization therapy and/or bradycardia pacing therapy. A first device located in the heart of the patient is configured to receive a communication from a second device and deliver a pacing therapy in response to or in accordance with the received communication. A second device located elsewhere is configured to determine an atrial event has occurred and communicate to the first device to trigger the pacing therapy. The second device may be configured for sensing the atrial event by the use of vector selection and atrial event windowing, among other enhancements. Exception cases are discussed and handled as well.
    Type: Application
    Filed: November 12, 2019
    Publication date: March 26, 2020
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: STEPHEN J. HAHN, KRZYSZTOF Z. SIEJKO, WILLIAM J. LINDER, KEITH R. MAILE, AMY JEAN BRISBEN, KEITH L. HERRMANN, BRENDAN E. KOOP, BENJAMIN J. HAASL
  • Publication number: 20200037887
    Abstract: Systems and methods for monitoring physiologic response to Valsalva maneuver (VM) are disclosed. An exemplary patient monitor may detect a natural incidence of a VM session occurred in an ambulatory setting using a heart sound (HS) signal sensed from the patient. The patient monitor may include a physiologic response analyzer to sense patient physiologic response during the detected VM session, and generate a cardiovascular or autonomic function indicator based on the sensed physiologic response to the VM. Using the physiologic response to the VM, the system may detect a target physiologic event using the sensed physiologic response to the VM.
    Type: Application
    Filed: July 18, 2019
    Publication date: February 6, 2020
    Inventors: Pramodsingh Hirasingh Thakur, David J. Ternes, Ashley Moriah Jensen, Qi An, Amy Jean Brisben
  • Patent number: 10512784
    Abstract: Systems, methods and implantable devices configured to provide cardiac resynchronization therapy and/or bradycardia pacing therapy. A first device located in the heart of the patient is configured to receive a communication from a second device and deliver a pacing therapy in response to or in accordance with the received communication. A second device located elsewhere is configured to determine an atrial event has occurred and communicate to the first device to trigger the pacing therapy. The second device may be configured for sensing the atrial event by the use of vector selection and atrial event windowing, among other enhancements. Exception cases are discussed and handled as well.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: December 24, 2019
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Stephen J. Hahn, Krzysztof Z. Siejko, William J. Linder, Keith R. Maile, Amy Jean Brisben, Keith L. Herrmann, Brendan E. Koop, Benjamin J. Haasl
  • Patent number: 10426405
    Abstract: In some examples, cardiac cycle detection may be used as a more or less default approach to cardiac activity tracking. Additional rate measurement relying on different sources or analyses may require extra power consumption over the cycle detection methods. Therefore, new methods and devices are disclosed that selectively activate a second cardiac rate measurement when needed. In some illustrative methods and devices, decisions are made as to whether and which previously collected data, if any, is to be discarded, replaced, or corrected upon activation of the second cardiac rate measurement.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: October 1, 2019
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Krzysztof Z. Siejko, Amy Jean Brisben, Stephen J. Hahn, Keith L. Herrmann, Venugopal Allavatam
  • Publication number: 20190275329
    Abstract: Systems and methods for pacing cardiac conductive tissue are described. A medical system includes an electrostimulation circuit to generate His-bundle pacing (HBP) pulses. A sensing circuit senses a physiologic signal, and detect a local His-bundle activation discrete from a pacing artifact of the HBP pulse. A control circuit verifies capture status in response to the HBP pulses. Based on the capture status, the control circuit determines one or more pacing thresholds including a selective HBP threshold representing a threshold strength to capture only the His bundle but not the local myocardium, and a non-selective HBP threshold representing a threshold strength to capture both the His bundle and the local myocardium. The electrostimulation circuit may deliver HBP pulses based on the selective and non-selective HBP thresholds.
    Type: Application
    Filed: January 24, 2019
    Publication date: September 12, 2019
    Inventors: Amy Jean Brisben, David J. Ternes, Allan Charles Shuros, Deepa Mahajan, David L. Perschbacher
  • Patent number: 10362948
    Abstract: Methods and devices for combining multiple signals from multiple sensing vectors for use in wearable or implantable cardiac devices. Signals from multiple vectors may be combined using weighting factors and/or by conversion to different coordinate systems than the original inputs, which may or may not be normalized to patient anatomy. Signals from multiple sensing vectors may be combined prior to or after several analytical steps or processes including before or after filtering, and before or after cardiac cycle detection. Cardiac cycle detection information may be combined across multiple sensing vectors before or after analysis of individual vectors for noise or overdetection. Cardiac cycle detection information may also be combined across multiple sensing vectors to identify noise and/or overdetection.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: July 30, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Amy Jean Brisben, Venugopal Allavatam, Deepa Mahajan, Krzysztof Z. Siejko, Kevin G. Wika, Keith L. Herrmann, Stephen J. Hahn
  • Publication number: 20190216348
    Abstract: New and alternative approaches to the monitoring of cardiac signal quality for external and/or implantable cardiac devices. In one example, signal quality is monitored continuously or in response to a triggering event or condition and, upon identification of a reduction in signal quality, a device may reconfigure its sensing state. In another example, one or more trends of signal quality are monitored by a device, either continuously or in response to a triggering event or condition, and sensing reconfiguration may be performed in response to identified trends and events. In yet another example, a device may use a looping data capture mode to track sensing data in multiple vectors while primarily relying on less than all sensing vectors to make decisions and, in response to a triggering event or condition, the looped data can be analyzed automatically, without waiting for additional data capture to reconfigure sensing upon identification of the triggering event or condition.
    Type: Application
    Filed: March 8, 2019
    Publication date: July 18, 2019
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Amy Jean Brisben, Venugopal Allavatam, Krzysztof Z. Siejko, Deepa Mahajan, Kevin G. Wika, Keith L. Herrmann, Stephen J. Hahn